These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 13682110)

  • 1. Some peculiar biological and biochemical properties of a mouse hepatoma induced by chrysoidin. II. Metabolic properties of the hepatoma.
    ALBERT Z; ORLOWSKI M
    J Natl Cancer Inst; 1960 Sep; 25():455-60. PubMed ID: 13682110
    [No Abstract]   [Full Text] [Related]  

  • 2. Some peculiar biological and biochemical properties of a mouse hepatoma induced by chrysoidin. III. Activity of glucose-6-phosphatase.
    ALBERT Z; ORLOWSKI M
    J Natl Cancer Inst; 1960 Sep; 25():461-4. PubMed ID: 13682111
    [No Abstract]   [Full Text] [Related]  

  • 3. Some biologic and metabolic properties of the 186th passage of mouse chrysoidin hepatoma.
    Rzucidlo Z; Starzyk H
    Arch Immunol Ther Exp (Warsz); 1968; 16(5):796-803. PubMed ID: 4303725
    [No Abstract]   [Full Text] [Related]  

  • 4. Presence and distribution of free porphyrins in transplants of a chrysoidin-induced mouse hepatoma.
    MEDRAS K
    J Natl Cancer Inst; 1960 Sep; 25():465-75. PubMed ID: 13768859
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrastructure of chrysoidin-induced hepatoma.
    DJACZENKO W; ALBERT Z
    Acta Med Pol; 1962; 3():307-21. PubMed ID: 14028139
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
    Uen YH; Ko PH; Yin PH; Liu TY; Chi CW; Lui WY
    Int J Oncol; 2008 Dec; 33(6):1263-70. PubMed ID: 19020760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiography of afferent and efferent blood vessels in transplantable chrysoidin hepatoma in mice.
    ALBERT Z; KUSTRZYCKI A; RZUCIDLO Z
    Acta Med Pol; 1963; 4():21-31. PubMed ID: 14011721
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical studies on the DAB-hepatocarcinogenesis. Comparative studies on normal rat liver, AH 130 ascites hepatoma and 3'-me-DAB-hepatoma especially at the level of subcellular particulates.
    SATO K
    Sci Rep Res Inst Tohoku Univ Med; 1961 Sep; 10():249-63. PubMed ID: 14038965
    [No Abstract]   [Full Text] [Related]  

  • 9. HISTOCHEMICAL DEMONSTRATION OF GLUCOSE-6-PHOSPHATASE IN TRANSPLANTABLE CHRYSOIDIN-INDUCED HEPATOMA.
    MALOLEPSZY J; PERYT B
    Arch Immunol Ther Exp (Warsz); 1963; 11():115-9. PubMed ID: 14062961
    [No Abstract]   [Full Text] [Related]  

  • 10. Phosphorylase activity in rat hepatoma and mouse mammary carcinoma transplants.
    GORANSON ES; McBRIDE J; WEBER G
    Cancer Res; 1954 Mar; 14(3):227-31. PubMed ID: 13150338
    [No Abstract]   [Full Text] [Related]  

  • 11. Concerning pathways of glucose utilization in mouse liver and hepatoma.
    ABRAHAM S; HILL R; CHAIKOFF IL
    Cancer Res; 1955 Mar; 15(3):177-80. PubMed ID: 14352211
    [No Abstract]   [Full Text] [Related]  

  • 12. Overexpression of regucalcin suppresses cell death and apoptosis in cloned rat hepatoma H4-II-E cells induced by insulin or insulin-like growth factor-I.
    Fukaya Y; Yamaguchi M
    J Cell Biochem; 2005 Sep; 96(1):145-54. PubMed ID: 15880694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development.
    Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor targeting by doxorubicin-RGD-4C peptide conjugate in an orthotopic mouse hepatoma model.
    Kim JW; Lee HS
    Int J Mol Med; 2004 Oct; 14(4):529-35. PubMed ID: 15375578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary observations on the transformation of energy in ascites hepatoma].
    CIARANFI E; FONNESU A
    Arch De Vecchi Anat Patol; 1960 Jun; 32():359-67. PubMed ID: 13693599
    [No Abstract]   [Full Text] [Related]  

  • 16. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
    Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
    Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells.
    Chan WH; Wu HJ; Hsuuw YD
    Ann N Y Acad Sci; 2005 May; 1042():372-8. PubMed ID: 15965083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid metabolism of Novikoff hepatoma.
    AUERBACH VH; WAISMAN HA
    Cancer Res; 1958 Jun; 18(5):543-7. PubMed ID: 13547047
    [No Abstract]   [Full Text] [Related]  

  • 19. The sensitivity of hepatoma and of liver succinoxidase to copper.
    FISHGOLD JT
    Stanford Med Bull; 1958 May; 16(2):83-6. PubMed ID: 13569038
    [No Abstract]   [Full Text] [Related]  

  • 20. Abnormal expression of hepatoma-derived gamma-glutamyltransferase subtyping and its early alteration for carcinogenesis of hepatocytes.
    Yao DF; Dong ZZ; Yao DB; Wu XH; Wu W; Qiu LW; Wang HM; Meng XY
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):564-70. PubMed ID: 15567746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.